Results 31 to 40 of about 105,793 (267)
Sexually Transmitted Infections [PDF]
Canadian Journal of Infectious Diseases and Medical Microbiology, 2005 Sexually transmitted infections (STIs) other than HIV have reappeared as an important public health problem in developed countries (1). In the late 1970s and early 1980s, research and treatment of the ′classic′ STIs ‐ gonorrhea, syphilis and chlamydia ‐ were a major focus of infectious diseases practice and research.
openaire +3 more sources
Detection and molecular characterization of urinary tract HIV-1 populations
Annals of Clinical Microbiology and Antimicrobials, 2019 Background Identification of all possible HIV reservoirs is an important aspect in HIV eradication efforts. The urinary tract has however not been well studied as a potential HIV reservoir.
M. L. Mzingwane +10 more
doaj +1 more source
Trials, 2022 Background Syphilis has recently resurfaced as a significant public health problem. Since the 2000s, isolated syphilis outbreaks have increasingly occurred in North America, Europe, and Australia; in Brazil, there have been progressive increases in both ...
Eliana M. Wendland +5 more
doaj +1 more source
Sexually transmitted infections
BMJ, 1998 Sexually transmitted infections are an important cause of morbidity and mortality throughout the world. Over 300 000 cases of sexually transmitted infection were diagnosed in genitourinary medicine clinics in England in 1996.1 Among these infections, the commonest were genital warts (over 50 000 first attacks), non-specific genital infection (over 50 ...
openaire +3 more sources
Tuberculosis and Sexually Transmitted Infections
Emerging Infectious Diseases, 2004 To the Editor: Mycobacterium tuberculosis infection is a necessary, but not sufficient, cause of tuberculosis (TB). Infection with HIV is the strongest known risk factor for disease progression to TB. In the absence of HIV infection, disease develops in 5% to 15% of infected persons.
Nagelkerke, Nico J.D. +3 more
openaire +4 more sources
A real-life study of the positive response to DAA-based therapies for hepatitis C in Brazil
Brazilian Journal of Infectious Diseases, 2021 A retrospective cohort of 11,308 chronic hepatitis C infected patients treated with regimens that included Sofosbuvir (SOF), Daclatasvir (DCV), Simeprevir (SMV), or an association of Ombitasvir, Veruprevir/Ritonavir and Dasabuvir (3D) with or without ...
Simone Monzani Vivaldini +5 more
doaj +1 more source
Health disparities in chronic liver disease
Hepatology, EarlyView., 2022 Abstract The syndemic of hazardous alcohol consumption, opioid use, and obesity has led to important changes in liver disease epidemiology that have exacerbated health disparities. Health disparities occur when plausibly avoidable health differences are experienced by socially disadvantaged populations.
Ani Kardashian +3 more
wiley +1 more source
EClinicalMedicine, 2022 Summary: Background: This systematic review aimed to compare body weight gain associated outcomes over time between dolutegravir (DTG)-based antiretroviral (ART) regimens to other ART regimens, to compare tenofovir alafenamide (TAF)-based regimens, and ...
Steve Kanters +7 more
doaj +1 more source
AIDS Research and Therapy, 2021 Background Uganda has registered a reduction in new HIV infections among children in recent years. However, mother-to-child transmission of HIV still occurs, especially among pregnant women who present late.
Yvette Wibabara +8 more
doaj +1 more source
Molecular Oncology, EarlyView.The cell‐autonomous roles of interferon type 1 vary based on duration and intensity. While acute, robust signaling results in cancer cell cytotoxic effects, sustained, low‐level signaling is associated with tumor‐promoting effects. This review summarizes current research of IFN‐1 in cancer and within the clinical setting, with an emphasis on female ...
Ashlyn Conant +7 more
wiley +1 more source